26
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Cisobitan® in Treatment of Prostatic Cancer

A Prospective Controlled Multicentre Study

, , , , , , , , , , , & show all
Pages 37-43 | Received 01 Apr 1981, Published online: 15 Feb 2010

REFERENCES

  • Albanus, L., Björklund, N. E., Gustafsson, B. & Jonsson, M. 1975. Forty days oral toxicity of 2,6-cis-diphenyl-hexamethylcyclotetrasiloxane (KABI 1774) in beagle dogs with special reference to effects on the male reproductive system. Acta Pharm Tox 36, Suppl. 3, 93.
  • Bhargava, A. S., Staben, P. & Günzel, P. 1979. Effects of high doses of the oestrogens 17 β-oestradiol and oestradiol valerate on blood components, coagulation and fibrinolysis in beagle dogs. Toxicology Letters 3, 95.
  • Bonucci de Matteis, A. 1975. Correlations between histological types and prognosis of prostatic carcinoma. Hormonal therapy of prostatic cancer. Proceedings of the international meeting, Rome. Cofese edizioni, Palermo.
  • Dobbs, R. M., Barber, J. A., Weigel, J. W. & Bergin, J. E. 1980. Clotting predisposition in carcinoma of the prostate. J Urol 123, 706.
  • Esposti, P. L. 1974. Aspiration biopsy cytology in the diagnosis and management of prostatic carcinoma. Thesis, Stockholm.
  • Hedlund, P. O., Gustafson, H. & Sjögren, S. 1980. Cardiovascular complications to treatment of prostate with estramustine phosphate (Estracyt®) or conventional estrogen. A follow-up of 212 randomized patients. Scand J Urol Nephrol, Suppl. 55, 103.
  • Palazzolo, R. J., McHard, J. A., Hobbs, E. J., Fancher, O. E. & Calandra, J. C. 1972. Investigation of the toxicologic properties of a phenylmethylcyclosiloxane. Toxicol Appl Pharmacol 21, 15.
  • Paulson, D. F., Berry, W. E., Cox, E. B., Walker, A. & Laszio, J. 1979. Treatment of metastatic endocrine-unresponsive carcinoma of the prostate gland with multiagent chemotherapy: indicators of response to therapy. J Nat Cancer Inst 63, 615.
  • Pilbrant, Å. & Strindberg, B. 1975. Pharmacokinetics of 2,6-cisdiphenylhexamethylcyclotetrasiloxane in man. Acta Pharmacol Toxicol 36, 139.
  • Schmidt, J. D., Gibbons, R. P., Johnson, D. E., Prout, G. R., Scott, W. W. & Murphy, G. P. 1976. Chemotherapy of advanced prostatic cancer, Evaluation of response parameters. Urology 7, 602.
  • Sundwall, A. 1980. Cisobitan—a new drug with anti-gonadotropic and anti-androgenic properties. Pharmacological effects. Scand J Nephrol suppl. 55, 121.
  • Vessman, J., Hammar, C. G., Lindeke, B., Strömberg, S., Levier, R., Robinson, R., Spielvogel, D. & Hanneman, L. 1978. Analysis of some organosilicon compounds in biological material. Biochemistry of silicon and related problems. Plenum Publishing Corp, p. 535.
  • TNM Classification of Malignant Tumours. 3rd ed. UICC International Union Against Cancer. Geneva 1978.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.